BRK-B vs BTZ

The deterministic health profile is weak, highlighted by a Piotroski F-Score of 3/9, indicating deteriorating operational efficiency and profitability trends. While the company maintains a fortress balance sheet with a Debt/Equity ratio of 0.19 and a Current Ratio of 7.07, the stock is trading at a significant premium to its growth-based intrinsic value of $217.21. Negative YoY revenue and earnings growth, coupled with a bearish technical trend, offset the positive analyst sentiment and long-term historical performance.

BTZ exhibits a stable financial health with a Piotroski F-Score of 6/9, indicating moderate strength, though the absence of an Altman Z-Score limits distress risk assessment. The stock appears undervalued relative to the Graham Number of $16.77 and intrinsic value of $32.45, trading at $10.57, but weak technical trends and declining revenue raise concerns. Exceptionally high profit margins and a 9.5% dividend yield are offset by a high payout ratio and deteriorating liquidity metrics. Relative to peers, BTZ has a lower P/E and higher yield but lags in revenue growth, warranting caution despite apparent value.